AHA 2024 Insights: Considerations in Care of Patients with Cancer: P…

AHA 2024 Insights

Y. Bryce

Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

MRI Imaging in Cardiotoxicity

Scripps Health

P. Parwani

How the Experts Manage: Cardiotoxicity and IO in NSCLC

MI&T Congressi

J. Remon Masip

Cardiotoxicity: Anthracyclines

Scripps Health

M. Davis

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

ACC 2024 Insights

J. Johnson

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Total Health

I. Rhea

Cardiotoxicity in Melanoma – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardiovascular Risk Assessment and Disease Management in Patients wi…

Georgia Heart Institute

B. Heimlich

Cardiac Disease in Breast Cancer: Background & Risk Factors

Total Health

I. Rhea

Cardiotoxicity in RCC – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardiotoxicity: Immunotherapy

Scripps Health

M. Davis

2024 Updates on Carcinoid Heart Disease

North American Neuroendocrine Tumor Society

A. Nohria

Cardiovascular Effects of Immune Checkpoint Inhibitors for Cancer: M…

The Texas Heart Institute

A. Deswal

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

Cardio-Oncology in Breast Cancer: Treatment Options for Immune Check…

Total Health

I. Rhea

ADT for Prostate Cancer and Cardiovascular Health Considerations

Andrew Hahn

2024 Update on Cancer and Cardiovascular Disease: The Conjoined Twins

Cleveland Clinic Taussig Cancer Institute

R. Moudgil